Study identifies 'turncoat' cells that fight—and aid—cancer

by Michael Masciadrelli,Yale UniversityCirculating tumor antigen reactive T cells in patients with advanced melanoma. Credit:Nature Immunology(2024). DOI: 10.1038/s41590-024-02023-4Y

Updated on: December 21,2024 0

Study identifies 'turncoat' cells that fight—and aid—cancer

by Michael Masciadrelli,Yale UniversityCirculating tumor antigen reactive T cells in patients with advanced melanoma. Credit:Nature Immunology(2024). DOI: 10.1038/s41590-024-02023-4Y

Updated on:December 21,2024 0

Sickle cell disease is a genetic disorder that causes lifelong suffering—here's what you need to know

by Cristina Pina and Victor Hernandez-Hernandez,The ConversationCredit: National Institutes of HealthRight now, approximately20 billion red blood cellsare busy traveling through your

Updated on: February 18,2025 0

Sickle cell disease is a genetic disorder that causes lifelong suffering—here's what you need to know

by Cristina Pina and Victor Hernandez-Hernandez,The ConversationCredit: National Institutes of HealthRight now, approximately20 billion red blood cellsare busy traveling through your

Updated on:February 18,2025 0

Predicting cardiac issues in cancer survivors using a serum protein panel test

bySt. Jude Children's Research HospitalUsing data from the St. Jude Lifetime Cohort (St. Jude LIFE), Yadav Sapkota, Ph.D., St. Jude Department of Epidemiology and Cancer Control, designed a

Updated on: December 20,2024 0

Predicting cardiac issues in cancer survivors using a serum protein panel test

bySt. Jude Children's Research HospitalUsing data from the St. Jude Lifetime Cohort (St. Jude LIFE), Yadav Sapkota, Ph.D., St. Jude Department of Epidemiology and Cancer Control, designed a

Updated on:December 20,2024 0

PIVKA-II-based model IDs liver cancer risk in hep C-related cirrhosis

by Elana GotkineAmong patients with hepatitis C virus (HCV)-related cirrhosis with sustained virological response (SVR) to direct-acting antivirals (DAAs), a serum protein induced by vitamin K absence

Updated on: December 20,2024 0

PIVKA-II-based model IDs liver cancer risk in hep C-related cirrhosis

by Elana GotkineAmong patients with hepatitis C virus (HCV)-related cirrhosis with sustained virological response (SVR) to direct-acting antivirals (DAAs), a serum protein induced by vitamin K absence

Updated on:December 20,2024 0

Machine learning uncovers three osteosarcoma subtypes for targeted treatment

byUniversity of East AngliaLatent process decomposition model optimization, subtype assignment and clinical outcome. Credit:Briefings in Bioinformatics(2024). DOI: 10.1093/bib/bbae66

Updated on: January 21,2025 0

Machine learning uncovers three osteosarcoma subtypes for targeted treatment

byUniversity of East AngliaLatent process decomposition model optimization, subtype assignment and clinical outcome. Credit:Briefings in Bioinformatics(2024). DOI: 10.1093/bib/bbae66

Updated on:January 21,2025 0

CRISPR study silences gene mutations that drive aggressive cancers

byPeter MacCallum Cancer CentreMolecular principles of CRISPR-Cas13 mismatch intolerance enable selective silencing of point-mutated oncogenic RNA with single-base precision. Credit:Scienc

Updated on: January 21,2025 0

CRISPR study silences gene mutations that drive aggressive cancers

byPeter MacCallum Cancer CentreMolecular principles of CRISPR-Cas13 mismatch intolerance enable selective silencing of point-mutated oncogenic RNA with single-base precision. Credit:Scienc

Updated on:January 21,2025 0

Algorithm helps guide cancer treatment using circulating tumor DNA from blood samples

byPeter MacCallum Cancer CentreCredit: Pixabay/CC0 Public DomainA breakthrough by researchers at Peter Mac will allow scientists to detect, analyze and profile cancer tumors in patients via a si

Updated on: December 20,2024 0

Algorithm helps guide cancer treatment using circulating tumor DNA from blood samples

byPeter MacCallum Cancer CentreCredit: Pixabay/CC0 Public DomainA breakthrough by researchers at Peter Mac will allow scientists to detect, analyze and profile cancer tumors in patients via a si

Updated on:December 20,2024 0

Abnormal prenatal blood test results could indicate hidden maternal cancers

byNIH/Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentCredit: Josh Willink from PexelsResearchers at the National Institutes of Health (NIH) found previously undet

Updated on: December 20,2024 0

Abnormal prenatal blood test results could indicate hidden maternal cancers

byNIH/Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentCredit: Josh Willink from PexelsResearchers at the National Institutes of Health (NIH) found previously undet

Updated on:December 20,2024 0

First look at neuron–tumor connections in brain illuminates formation and spread of gliomas

by Stephanie Dutchen,Harvard Medical SchoolResearchers revealed which neurons in a mouse brain, shown in red, connect to a human glioma, shown in green. Image: Annie Hsieh. Credit:Proceedi

Updated on: December 20,2024 0

First look at neuron–tumor connections in brain illuminates formation and spread of gliomas

by Stephanie Dutchen,Harvard Medical SchoolResearchers revealed which neurons in a mouse brain, shown in red, connect to a human glioma, shown in green. Image: Annie Hsieh. Credit:Proceedi

Updated on:December 20,2024 0

Proof-of-concept study bioengineers therapeutics for improved cancer treatment

by Children's Medical Research InstituteCredit: Pixabay/CC0 Public DomainA team of Children's Medical Research Institute (CMRI) scientists has identified a new method for producing a therapeut

Updated on: January 21,2025 0

Proof-of-concept study bioengineers therapeutics for improved cancer treatment

by Children's Medical Research InstituteCredit: Pixabay/CC0 Public DomainA team of Children's Medical Research Institute (CMRI) scientists has identified a new method for producing a therapeut

Updated on:January 21,2025 0

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patientsby NRG OncologyCredit: Pixabay/CC0 Public DomainRecent results from the Phase III NRG-RT

Updated on: January 21,2025 0

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patientsby NRG OncologyCredit: Pixabay/CC0 Public DomainRecent results from the Phase III NRG-RT

Updated on:January 21,2025 0

Oncologist discusses treating liver cancer

by Mayo Clinic News NetworkCredit: Pixabay/CC0 Public DomainLiver cancer rates have more than tripled in the U.S. since 1980 and continue to rise. More than 41,000 people will be diagnosed with liver

Updated on: January 21,2025 0

Oncologist discusses treating liver cancer

by Mayo Clinic News NetworkCredit: Pixabay/CC0 Public DomainLiver cancer rates have more than tripled in the U.S. since 1980 and continue to rise. More than 41,000 people will be diagnosed with liver

Updated on:January 21,2025 0